Brad Ringeisen is the Executive Director of the Innovative Genomics Institute (IGI), founded by Jennifer Doudna in 2014 on the University of California, Berkeley campus. Brad’s primary role is to guide IGI’s scientific and development strategy, but his duties also include promoting entrepreneurship, working with biotech investors and companies to ensure commercial translation of our technologies, donor outreach and development, scientific project development and team building, communication with campus leadership, personnel management and mentoring, program management, and reporting and...
